FindTrial
Sign In

impact of intelligent management platform on the self-management and psychological changes in glaucoma patients.

impact of intelligent management platform on the self-management and psychological changes in glaucoma patients.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042527
Enrollment
Unknown
Registered
2021-01-23
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

intervention group:Use the glaucoma management platform based on WeChat miniprogram
control group:Nil

Sponsors

Department of Glaucoma, Ophthalmology Center, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The first diagnosed is glaucoma; 2. Aged 18-60 years; 3. The best corrected visual acuity >= 0.3 for both eyes; 4. Able to use WeChat miniprogram and surf the Internet with mobile phone; 5. Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Patients with hearing abnormalities or low vision (best corrected visual acuity <0.3 in both eyes for good eyes); 2. Obstacle in cognitive function and language communication; 3. Patients without glaucoma as the first diagnosis; 4. Complicated with other serious eye diseases and systemic diseases; 5. Researchers don't think it fits the study.

Design outcomes

Primary

MeasureTime frame
The glaucoma self-management behavior questionnaire was used to evaluate the effect of patients' self-management.;—

Countries

China

Contacts

Public ContactHuang Wenmin

Ophthalmic Center of Sun Yat-Sen University

huangwenmin@163.com+86 13676260840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026